Wyeth Pharmaceuticals is continuing efforts to improve its capabilities in the formulation and delivery of RNA through a strategic partnership with Santaris Pharma.
Complete data analysis in the time it takes many laboratories to
take the first steps. This is what Ambion is offering with its new
microRNA expression profiling service, claimed to surpass any
similar offerings in the market.
Researchers have shown how protein synthesis is targeted to certain
regions of a cell, a process crucial for the cellular motility,
which could form a basis for producing a drug that could force
tumour cells to express this protein,...
Benetic has announced the signing of two major agreements, one that
grants Sigma-Aldrich license for the use of Benitec's RNAi
technology. Sigma's acquisition of an equity stake in Benitec also
signals its intentions regarding...
New techniques aimed at directly controlling the expression of
genes by activating or inactivating them at the DNA level could
lead to drugs for the treatment or cure of almost any disease, say
researchers